NO993927L - Farmasöytiske blandinger i törr form for oral administrasjon av en syklisk kvaternær ammoniumforbindelse - Google Patents

Farmasöytiske blandinger i törr form for oral administrasjon av en syklisk kvaternær ammoniumforbindelse

Info

Publication number
NO993927L
NO993927L NO993927A NO993927A NO993927L NO 993927 L NO993927 L NO 993927L NO 993927 A NO993927 A NO 993927A NO 993927 A NO993927 A NO 993927A NO 993927 L NO993927 L NO 993927L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
quaternary ammonium
oral administration
ammonium compound
dry pharmaceutical
Prior art date
Application number
NO993927A
Other languages
English (en)
Norwegian (no)
Other versions
NO993927D0 (no
Inventor
Bernard Abramovici
Xavier Boulenc
Jean-Claude Gautier
Pol Vilain
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO993927D0 publication Critical patent/NO993927D0/no
Publication of NO993927L publication Critical patent/NO993927L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO993927A 1997-02-17 1999-08-16 Farmasöytiske blandinger i törr form for oral administrasjon av en syklisk kvaternær ammoniumforbindelse NO993927L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701826A FR2759585B1 (fr) 1997-02-17 1997-02-17 Formulations pharmaceutiques presentees sous forme seche pour l'administration orale d'un compose ammonium quaternaire cyclique
PCT/FR1998/000299 WO1998035663A1 (fr) 1997-02-17 1998-02-17 Formulations pharmaceutiques presentees sous forme seche pour l'administration orale d'un compose ammonium quaternaire cyclique

Publications (2)

Publication Number Publication Date
NO993927D0 NO993927D0 (no) 1999-08-16
NO993927L true NO993927L (no) 1999-08-16

Family

ID=9503805

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993927A NO993927L (no) 1997-02-17 1999-08-16 Farmasöytiske blandinger i törr form for oral administrasjon av en syklisk kvaternær ammoniumforbindelse

Country Status (19)

Country Link
US (1) US6303626B1 (xx)
EP (1) EP0981340B1 (xx)
JP (1) JP2001511796A (xx)
AR (1) AR011806A1 (xx)
AT (1) ATE210436T1 (xx)
AU (1) AU6405098A (xx)
BR (1) BR9807406A (xx)
CA (1) CA2281607A1 (xx)
CO (1) CO4920216A1 (xx)
DE (1) DE69802921T2 (xx)
DK (1) DK0981340T3 (xx)
ES (1) ES2172116T3 (xx)
FR (1) FR2759585B1 (xx)
HK (1) HK1023509A1 (xx)
HR (1) HRP980074A2 (xx)
NO (1) NO993927L (xx)
PT (1) PT981340E (xx)
WO (1) WO1998035663A1 (xx)
ZA (1) ZA981288B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151769A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
US20060210625A1 (en) * 2003-11-04 2006-09-21 Shire Laboratories, Inc. Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms
DE10355461A1 (de) * 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
CN102188424B (zh) * 2011-03-23 2013-03-27 浙江理工大学 Sr140333的抗血癌作用
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
WO2014151901A1 (en) * 2013-03-14 2014-09-25 Abbvie Inc. Improvement of mammalian cell culture performance through surfactant supplementation of feed media
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676054B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2688219B1 (fr) * 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
FR2696178B1 (fr) * 1992-09-30 1994-12-30 Sanofi Elf Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant.
US5679693A (en) 1992-09-30 1997-10-21 Sanofi 1-azoniabicyclo 2.2.1!heptanes, method of preparing them and pharmaceutical compositions in which they are present
FR2717804B1 (fr) * 1994-03-25 1996-06-21 Sanofi Sa Sels de composés hétéroaromatiques azotés substitués, procédé pour leur préparation et compositions pharmaceutiques en contenant.
FR2717802B1 (fr) * 1994-03-25 1996-06-21 Sanofi Sa Nouveaux composés aromatiques, procédé pour leur préparation et compositions pharmaceutiques en contenant.
MX9701305A (es) * 1994-08-25 1998-05-31 Merrell Pharma Inc Piperidinas sustituidas novedosas utiles para el tratamiento de enfermedades alergicas.
FR2725986B1 (fr) 1994-10-21 1996-11-29 Adir Nouveaux derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2725900B1 (fr) * 1994-10-21 1997-07-18 Sanofi Sa Utilisation d'antagonistes des recepteurs nk1 pour la preparation de medicaments a action cardioregulatrice
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2729951B1 (fr) 1995-01-30 1997-04-18 Sanofi Sa Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant

Also Published As

Publication number Publication date
DK0981340T3 (da) 2002-03-25
CO4920216A1 (es) 2000-05-29
FR2759585B1 (fr) 1999-06-11
BR9807406A (pt) 2000-03-14
AR011806A1 (es) 2000-09-13
ATE210436T1 (de) 2001-12-15
NO993927D0 (no) 1999-08-16
AU6405098A (en) 1998-09-08
HRP980074A2 (en) 1998-10-31
ES2172116T3 (es) 2002-09-16
FR2759585A1 (fr) 1998-08-21
ZA981288B (en) 1998-08-26
PT981340E (pt) 2002-05-31
JP2001511796A (ja) 2001-08-14
DE69802921D1 (de) 2002-01-24
DE69802921T2 (de) 2002-08-29
EP0981340B1 (fr) 2001-12-12
CA2281607A1 (en) 1998-08-20
EP0981340A1 (fr) 2000-03-01
WO1998035663A1 (fr) 1998-08-20
US6303626B1 (en) 2001-10-16
HK1023509A1 (en) 2000-09-15

Similar Documents

Publication Publication Date Title
FI963984A (fi) Uusi oraalinen farmaseuttinen annostelumuoto
PT1043977E (pt) Forma de dosagem farmaceutica oral de libertacao por impulsos
NO995809D0 (no) Farmasöytisk formulering av omeprazol
DK0876131T3 (da) Sammensætninger til lægemiddelindgivelse til forbedret stabilitet af androgener
NO994757D0 (no) FramgangsmÕte for oral administrasjon av proteiner
ATE206924T1 (de) Oral anzuwendende arzneizubereitung enthaltend olanzapin
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
EE200000383A (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
NO993927D0 (no) Farmasöytiske blandinger i törr form for oral administrasjon av en syklisk kvaternær ammoniumforbindelse
FI954007A0 (fi) Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena
EE200200075A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kompositsioonid
NO20014738L (no) Tolperisonholdig farmasöytisk preparat for oral administrering
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
NO996044L (no) Rapamycinformuleringer for oral administrasjon
NO975680D0 (no) Oralt, farmasöytisk preparat av piperidinoalkanol-forbindelser i opplösningsform
NO20003393D0 (no) FremgangsmÕte for fremstilling av en farmasøytisk formulering
EE200100196A (et) a-tsüklodekstriinil põhinevad farmatseutilised kompositsioonid LH-RH analoogide peroraalseks manustamiseks
NO20003284D0 (no) Farmasøytisk preparat for oral administrering
NO20001749D0 (no) Fremstilling av asymmetriske sykliske ureaforbindelser via et monoacylert diaminintermediat
ZA981289B (en) Pharmaceutical composition for the oral administration of heterocyclic compounds in quaternary ammonium form
DK1165081T3 (da) Fremgangsmåde til fremstilling af tolperisonholdige farmaceutiske præparater til oral indgivelse
SE9402433D0 (sv) New oral pharmaceutical dosage form

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application